Innovative medical devices and hospital decision making: a study comparing the views of hospital pharmacists and physicians

Australian Health Review : a Publication of the Australian Hospital Association
Mathilde BillauxN Martelli

Abstract

Objectives Many university hospitals have developed local health technology assessment processes to guide informed decisions about new medical devices. However, little is known about stakeholders' perceptions and assessment of innovative devices. Herein, we investigated the perceptions regarding innovative medical devices of their chief users (physicians and surgeons), as well as those of hospital pharmacists, because they are responsible for the purchase and management of sterile medical devices. We noted the evaluation criteria used to assess and select new medical devices and suggestions for improving local health technology assessment processes indicated by the interviewees. Methods We randomly selected 18 physicians and surgeons (nine each) and 18 hospital pharmacists from 18 French university hospitals. Semistructured interviews were conducted between October 2012 and August 2013. Responses were coded separately by two researchers. Results Physicians and surgeons frequently described innovative medical devices as 'new', 'safe' and 'effective', whereas hospital pharmacists focused more on economic considerations and considered real innovative devices to be those for which no equivalent could be found on the market. No sign...Continue Reading

References

Jan 5, 2000·BMJ : British Medical Journal·N Mays, C Pope
Dec 12, 2000·The Western Journal of Medicine·M E GinsburgW A Sandberg
Jan 25, 2003·Health Policy·David Banta
Jun 25, 2003·World Journal of Surgery·Martin F McKneally, Abdallah S Daar
Jan 6, 2005·Journal of the American College of Surgeons·Angelique M Reitsma, Jonathan D Moreno
Apr 1, 2006·Medical Education·Barbara Dicicco-Bloom, Benjamin F Crabtree
May 2, 2007·Cleveland Clinic Journal of Medicine·Paul A LaViolette
Oct 17, 2007·International Journal of Technology Assessment in Health Care·John HuttonChristopher Henshall
Nov 21, 2007·Journal of Health Economics·David M Cutler
May 27, 2008·Journal of the American College of Surgeons·Walter L BifflUNKNOWN Society of University Surgeons Surgical Innovations Project Team
Aug 1, 2008·Australian Health Review : a Publication of the Australian Hospital Association·Gisselle GallegoKees van Gool
Mar 11, 2009·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Marilyn Dix SmithDiana Brixner
Jun 19, 2009·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·John C O'DonnellMarilyn Dix Smith
Jul 9, 2009·Journal of Vascular and Interventional Radiology : JVIR·Mark Otto BaerlocherJohn F Cardella
Jun 30, 2010·International Journal of Technology Assessment in Health Care·Matthew D MitchellCraig A Umscheid
May 17, 2011·BMJ : British Medical Journal·Deborah Cohen, Matthew Billingsley
Feb 16, 2012·The New England Journal of Medicine·Daniel B KramerAaron S Kesselheim
Sep 18, 2012·International Journal of Technology Assessment in Health Care·Frank HulstaertHans van Brabandt
Mar 21, 2013·Journal of Evaluation in Clinical Practice·Aurélie BoudardJudith Pineau
Jun 22, 2013·Annals of Surgery·Wendy A RogersAnthony Eyers
Jun 29, 2013·ClinicoEconomics and Outcomes Research : CEOR·Corinna SorensonBeena Bhuiyan Khan
Jul 31, 2013·American Heart Journal·Doron SudarskyShahar Lavi
Jan 8, 2014·Health Affairs·Kanu OkikeChristopher T Lebrun

❮ Previous
Next ❯

Citations

Jun 20, 2020·Therapeutic Innovation & Regulatory Science·Teodora MiclăuşEfstathios Vassiliadis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.